UK Study Integrates PrecivityAD2 Blood Test for Alzheimer’s in Primary Care
Researchers in the United Kingdom are integrating the PrecivityAD2 blood test from C2N Diagnostics into the Alzheimer’s disease…
United Kingdom Researchers Integrate C2N’s PrecivityAD2® Blood Test Into the Alzheimer’s Disease Diagnostic Care Pathway
ST. LOUIS, July 29, 2026–(BUSINESS WIRE)–Researchers in the United Kingdom are using the PrecivityAD2® blood test from C2N…